Millennium Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $358K | Sell |
|
|||||
|
2025
Q2 | $483K | Sell |
|
|||||
|
2025
Q1 | $2.6M | Buy |
|
|||||
|
2024
Q4 | $1.81M | Buy |
|
|||||
|
2024
Q3 | $908K | Buy |
|
|||||
|
2024
Q2 | $528K | Buy |
|
|||||
|
2024
Q1 | $538K | Sell |
|
|||||
|
2023
Q4 | $1.35M | Sell |
|
|||||
|
2023
Q3 | $1.96M | Buy |
|
|||||
|
2023
Q2 | $184K | Sell |
|
|||||
|
2023
Q1 | $1.52M | Sell |
|
|||||
|
2022
Q4 | $7.58M | Buy |
|
|||||
|
2022
Q3 | $6.6M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $170K | Sell |
|
|||||
|
2021
Q4 | $260K | Sell |
|
|||||
|
2021
Q3 | $7M | Buy |
|
|||||
|
2021
Q2 | $2.19M | Buy |
|
|||||
|
2021
Q1 | $2.43M | Buy |
|
|||||
|
2020
Q4 | $431K | Buy |
|
|||||
|
2020
Q3 | $246 | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2.6M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $377K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $4.3M | Buy |
|
|||||
|
2018
Q2 | $979K | Sell |
|
|||||
|
2018
Q1 | $1.63M | Buy |
|
|||||
|
2017
Q4 | $419K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $619K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.03M | Sell |
|
|||||
|
2015
Q3 | $1.35M | Buy |
|
|||||
|
2015
Q2 | $590K | Sell |
|
|||||
|
2015
Q1 | $876K | Sell |
|
|||||
|
2014
Q4 | $2.21M | Buy |
|
|||||
|
2014
Q3 | $237K | Buy |
|